These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 9270085

  • 1. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
    Os I, Hotnes T, Dollerup J, Mogensen CE.
    Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
    Freytag F, Schelling A, Meinicke T, Deichsel G, Telmisartan Hypertension Experience in a Randomized European Study Versus Atenolol Study Group.
    Clin Ther; 2001 Jan; 23(1):108-23. PubMed ID: 11219471
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
    Chrysant SG, Stimpel M.
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):384-90. PubMed ID: 9514183
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R, Marx A, Haller H.
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [Abstract] [Full Text] [Related]

  • 5. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.
    Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S.
    BMJ; 1997 Jul 19; 315(7101):154-9. PubMed ID: 9251545
    [Abstract] [Full Text] [Related]

  • 6. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH, Hietanen EK, Salo TT, Kataja MJ, Kantola IM.
    Am J Hypertens; 1998 Mar 19; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.
    Malmqvist K, Kahan T, Dahl M.
    Am J Hypertens; 2000 May 19; 13(5 Pt 1):504-11. PubMed ID: 10826401
    [Abstract] [Full Text] [Related]

  • 8. Combination of enalapril and low-dose thiazide reduces normoalbuminuria in essential hypertension.
    Nielsen S, Dollerup J, Nielsen B, Mogensen CE.
    J Hypertens; 1998 Oct 19; 16(10):1539-44. PubMed ID: 9814627
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S, Aurup P, Snavely D, Goldberg A.
    Am J Cardiol; 2001 Mar 15; 87(6):721-6. PubMed ID: 11249890
    [Abstract] [Full Text] [Related]

  • 10. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Romero R, Castellote E, Ocón J, Wagner B.
    J Cardiovasc Pharmacol; 1995 Jul 15; 26(1):114-8. PubMed ID: 7564350
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun 15; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

  • 12. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K, Gerhardt G, Lehmann G, Notter T, Belz GG.
    Int J Clin Pharmacol Ther; 1998 Aug 15; 36(8):425-31. PubMed ID: 9726695
    [Abstract] [Full Text] [Related]

  • 13. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
    Kraiczi H, Hedner J, Peker Y, Grote L.
    Am J Respir Crit Care Med; 2000 May 15; 161(5):1423-8. PubMed ID: 10806134
    [Abstract] [Full Text] [Related]

  • 14. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW, INVEST Investigators.
    JAMA; 2003 Dec 03; 290(21):2805-16. PubMed ID: 14657064
    [Abstract] [Full Text] [Related]

  • 15. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
    Silagy CA, McNeil JJ, McGrath BP.
    Am J Cardiol; 1992 Nov 15; 70(15):1299-305. PubMed ID: 1442581
    [Abstract] [Full Text] [Related]

  • 16. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
    Magvanjav O, Gong Y, McDonough CW, Chapman AB, Turner ST, Gums JG, Bailey KR, Boerwinkle E, Beitelshees AL, Tanaka T, Kubo M, Pepine CJ, Cooper-DeHoff RM, Johnson JA.
    J Am Heart Assoc; 2017 Nov 02; 6(11):. PubMed ID: 29097388
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep 02; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 18. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E, Anson O, Neumann L.
    Am J Hypertens; 1996 Dec 02; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
    Chrysant SG, Weber MA, Wang AC, Hinman DJ.
    Am J Hypertens; 2004 Mar 02; 17(3):252-9. PubMed ID: 15001200
    [Abstract] [Full Text] [Related]

  • 20. Hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment. Influence on LVH, proteinuria and metabolic parameters. The HANE Trial Research Group.
    Kribben A, Anlauf M, Distler A, Gärtner H, Holzgreve H, Michaelis J, Röcker L, Schäfers R, Philipp U, Wellek S, Philipp T.
    Kidney Int Suppl; 1997 Oct 02; 61():S74-6. PubMed ID: 9328972
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.